Toxic anterior segment syndrome (TASS) is identified by aseptic postoperative inflammation of the front part of the eye after intraocular surgery. While TASS usually appears after cataract surgery, it has also been observed after keratoplasty and surgeries involving the back part of the eye.
The inflammation can range from mild with a low cellular response to severe enough to cause significant cornea swelling and hypopyon. It can occur rapidly (within days) or later (after several months). A broad case series found the overall occurrence of TASS to be 0.22%.
Epidemiology
Incidence: The reported incidence of TASS varies across studies. The incidence rates range from 0.03% to 3% of cases following cataract surgery.
Visual outcome: The visual result after TASS treatment varies based on the seriousness of the ailment and the promptness of intervention. With proper care, most patients observe considerable enhancement in their visual sharpness.
Outbreaks: it can sometimes occur in multiple cases, impacting numerous patients in a particular period and area. Outbreaks are usually linked to a shared origin of pollution or incorrect medical procedures.
Precautionary measures: The occurrence of TASS has reduced with time owing to better comprehension and compliance with aseptic protocols. Medical facilities have emphasized improving sterilization methods for instruments, appropriate storage, and preparation of irrigation solutions.
Anatomy
Pathophysiology
Toxic anterior segment syndrome is a consequence of the accidental introduction of noxious agents into the front part of the eye. This triggers a significant inflammatory response that can differ in severity depending on the nature and duration of the harmful substance.
The acute and severe inflammatory reaction is due to cellular necrosis or apoptosis as well as damage to the surrounding tissue. The corneal endothelium is frequently the most affected structure, as it is not able to regenerate or replace deceased cells.
Toxic agents specifically trigger the sudden disintegration of endothelial connections, resulting in the loss of the barrier’s functionality. Therefore, the surviving endothelial cells attempt to uphold the endothelial pumping mechanism by migrating and extending over the affected regions.
Etiology
Residual sterilization agents: Improper rinsing or inadequate removal of sterilizing agents used for surgical instruments can lead to their introduction into the eye during surgery.
Ophthalmic visco-surgical devices (OVDs): OVDs are commonly used during cataract surgery to maintain the stability of the anterior chamber and protect delicate tissues.
Improperly prepared irrigating solutions: The irrigating solutions used during surgery, such as balanced salt solutions, can be a potential source of contaminants.
Genetics
Prognostic Factors
These factors can help clinicians assess the prognosis and guide treatment decisions.
Severity of Inflammation: The scope and seriousness of inflammation in the front part of the eye have an impact on the prediction of TASS.
Fundamental Eye Health: Individuals with weakened eye structures, such as pre-existing corneal illness or glaucoma, may face more difficulties in controlling the inflammation and obtaining the best visual results.
Response to Treatment: Patients who exhibit a timely and favorable response to anti-inflammatory treatments, such as topical or systemic corticosteroids, generally have a better prediction than those with a poor response or stubborn inflammation.
Clinical History
CLINICAL HISTORY
Age Group: Toxic Anterior Segment Syndrome (TASS) can affect individuals across various age groups, including both younger and older individuals.
Physical Examination
PHYSICAL EXAMINATION
Slit Lamp Examination: A slit lamp biomicroscope is used to examine the anterior segment of the eye in detail. It includes mainly,
Swelling of the Cornea: The cornea might display indications of puffiness or swelling, causing a cloudy or indistinct appearance. The amount of corneal swelling can differ based on the harshness of TASS.
Fibrin or hypopyon: In serious circumstances, fibrin could be detected in the front chamber, showing up as slimy or lumpy substance.
Redness of the Conjunctiva: The conjunctiva may seem crimson or irritated due to the existence of inflammation in the front part.
Visual Acuity: Visual acuity is measured using a Snellen chart or an appropriate visual acuity test.
Age group
Associated comorbidity
Associated Comorbidity or Activity:
Systemic Health Conditions: Some general health conditions can impact the overall health and ability to heal of the eye, which could potentially impact the development and outcome of TASS.
Hypersensitivities and Allergies: People with known sensitivities or a past of allergic reactions may have a higher chance of developing TASS.
Previous Eye Operations: Individuals who have had previous intraocular surgeries or experienced complications from ocular procedures may be more prone to TASS.
Associated activity
Acuity of presentation
Acuity of Presentation:
The visual acuity at presentation of Toxic Anterior Segment Syndrome (TASS) may differ based on the gravity of the ailment and the patient. Generally, TASS presents within the initial 12 to 48 hours after intraocular surgery, predominantly cataract surgery.
Unaffected Visual Acuity: TASS may present with minimal influence on visual acuity. The individual might encounter indications like agony, inflammation, and uneasiness in the affected eye, but their visual acuity could continue to be relatively steady or only slightly impacted.
Reduced Visual Acuity: TASS frequently manifests with a reduction in visual acuity. The inflammation and swelling in the front section can lead to hazy vision, reduced sharpness, and impaired visual performance.
Differential Diagnoses
DIFFERENTIAL DIAGNOSIS
Endophthalmitis: It is a serious infection within the eye that can happen after eye surgery. It shows similar symptoms to TASS, such as pain, redness, reduced visual acuity, and inflammation of the front chamber.
Sterile Inflammation: Some patients may experience an aseptic inflammatory reaction after eye surgery, which can imitate the signs and symptoms of TASS.
Anterior Uveitis: Non-infectious anterior uveitis or iritis can present with anterior chamber inflammation, pain, redness, and decreased visual acuity.
Corneal Decompensation: Patients with pre-existing corneal endothelial dysfunction or corneal diseases may experience corneal decompensation after eye surgery. Corneal decompensation can show up with corneal swelling, hazy vision, and decreased visual acuity.
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
TREATMENT PARADIGM
Modification of Environment:
These can be an important aspect of managing Toxic Anterior Segment Syndrome (TASS) to minimize further exposure to potential contaminants and support the healing process.
Surgical Environment: Enforcing sterile measures in the operating room is vital in avoiding the development of TASS.
Surgical Apparatus and Materials: Conducting periodic assessments and upkeep of surgical apparatus and materials are imperative in averting pollution and the influx of harmful elements.
Irrigation Fluids: Exercising caution and diligence in scrutinizing the composition and standard of irrigation fluids utilized during surgery is indispensable.
Administration of Pharmaceutical Agents with Drugs:
The administration of pharmaceutical agents in the management of Toxic Anterior Segment Syndrome (TASS) aims to control inflammation, alleviate symptoms, and promote healing.
Nonsteroidal Anti-Inflammatory drugs (NSAIDs): Topical NSAIDs can be suggested as a complement to steroids or as a substitute in specific situations. They help in reducing pain, inflammation, and related symptoms. Ketorolac tromethamine, nepafenac, or bromfenac are some of the frequently used NSAIDs.
Artificial Lubricants: Eye drops that lubricate or artificial tears might be advised to alleviate dryness and enhance comfort in TASS. They assist in preserving the hydration of the ocular surface and mitigating symptoms of dryness and irritation.
Intervention with a Procedure:
Capsular Bag rinse or Replacement: If there are indications of any remaining pollutants or harmful substances inside the lens capsule post cataract surgery, a capsular bag irrigation or replacement could be contemplated.
Laser Capsulotomy: In some cases, posterior capsule opacification (PCO) may arise simultaneously with TASS or because of the inflammatory reaction. PCO can lead to visual disruptions and may necessitate treatment.
Phase of Management:
Initial Diagnosis: The initial step comprises of timely identification and diagnosis of TASS. This necessitates a heightened level of suspicion grounded on the patient’s indications, clinical examination outcomes, and familiarity with the surgical procedure conducted.
Immediate treatment: Upon confirmation of TASS, prompt management is commenced to manage inflamed areas, alleviate indications, and prevent additional harm. This encompasses the dispensation of topical drugs like corticosteroids and NSAIDs to decrease inflammation and alleviate discomfort.
Supportive Care: Supportive care is an essential aspect of TASS management. It includes measures to maintain ocular hygiene, promote comfort, and prevent complications.
Rehabilitation and Visual Recovery: Once the acute phase of TASS is resolved, rehabilitation and visual recovery become the focus. This may involve addressing any residual visual impairment and managing posterior capsule opacification.
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
Medication
Future Trends
Media Gallary
References
Toxic anterior segment syndrome-an updated review | BMC Ophthalmology | Full Text (biomedcentral.com)
Toxic anterior segment syndrome (TASS) is identified by aseptic postoperative inflammation of the front part of the eye after intraocular surgery. While TASS usually appears after cataract surgery, it has also been observed after keratoplasty and surgeries involving the back part of the eye.
The inflammation can range from mild with a low cellular response to severe enough to cause significant cornea swelling and hypopyon. It can occur rapidly (within days) or later (after several months). A broad case series found the overall occurrence of TASS to be 0.22%.
Incidence: The reported incidence of TASS varies across studies. The incidence rates range from 0.03% to 3% of cases following cataract surgery.
Visual outcome: The visual result after TASS treatment varies based on the seriousness of the ailment and the promptness of intervention. With proper care, most patients observe considerable enhancement in their visual sharpness.
Outbreaks: it can sometimes occur in multiple cases, impacting numerous patients in a particular period and area. Outbreaks are usually linked to a shared origin of pollution or incorrect medical procedures.
Precautionary measures: The occurrence of TASS has reduced with time owing to better comprehension and compliance with aseptic protocols. Medical facilities have emphasized improving sterilization methods for instruments, appropriate storage, and preparation of irrigation solutions.
Toxic anterior segment syndrome is a consequence of the accidental introduction of noxious agents into the front part of the eye. This triggers a significant inflammatory response that can differ in severity depending on the nature and duration of the harmful substance.
The acute and severe inflammatory reaction is due to cellular necrosis or apoptosis as well as damage to the surrounding tissue. The corneal endothelium is frequently the most affected structure, as it is not able to regenerate or replace deceased cells.
Toxic agents specifically trigger the sudden disintegration of endothelial connections, resulting in the loss of the barrier’s functionality. Therefore, the surviving endothelial cells attempt to uphold the endothelial pumping mechanism by migrating and extending over the affected regions.
Residual sterilization agents: Improper rinsing or inadequate removal of sterilizing agents used for surgical instruments can lead to their introduction into the eye during surgery.
Ophthalmic visco-surgical devices (OVDs): OVDs are commonly used during cataract surgery to maintain the stability of the anterior chamber and protect delicate tissues.
Improperly prepared irrigating solutions: The irrigating solutions used during surgery, such as balanced salt solutions, can be a potential source of contaminants.
These factors can help clinicians assess the prognosis and guide treatment decisions.
Severity of Inflammation: The scope and seriousness of inflammation in the front part of the eye have an impact on the prediction of TASS.
Fundamental Eye Health: Individuals with weakened eye structures, such as pre-existing corneal illness or glaucoma, may face more difficulties in controlling the inflammation and obtaining the best visual results.
Response to Treatment: Patients who exhibit a timely and favorable response to anti-inflammatory treatments, such as topical or systemic corticosteroids, generally have a better prediction than those with a poor response or stubborn inflammation.
CLINICAL HISTORY
Age Group: Toxic Anterior Segment Syndrome (TASS) can affect individuals across various age groups, including both younger and older individuals.
PHYSICAL EXAMINATION
Slit Lamp Examination: A slit lamp biomicroscope is used to examine the anterior segment of the eye in detail. It includes mainly,
Swelling of the Cornea: The cornea might display indications of puffiness or swelling, causing a cloudy or indistinct appearance. The amount of corneal swelling can differ based on the harshness of TASS.
Fibrin or hypopyon: In serious circumstances, fibrin could be detected in the front chamber, showing up as slimy or lumpy substance.
Redness of the Conjunctiva: The conjunctiva may seem crimson or irritated due to the existence of inflammation in the front part.
Visual Acuity: Visual acuity is measured using a Snellen chart or an appropriate visual acuity test.
Associated Comorbidity or Activity:
Systemic Health Conditions: Some general health conditions can impact the overall health and ability to heal of the eye, which could potentially impact the development and outcome of TASS.
Hypersensitivities and Allergies: People with known sensitivities or a past of allergic reactions may have a higher chance of developing TASS.
Previous Eye Operations: Individuals who have had previous intraocular surgeries or experienced complications from ocular procedures may be more prone to TASS.
Acuity of Presentation:
The visual acuity at presentation of Toxic Anterior Segment Syndrome (TASS) may differ based on the gravity of the ailment and the patient. Generally, TASS presents within the initial 12 to 48 hours after intraocular surgery, predominantly cataract surgery.
Unaffected Visual Acuity: TASS may present with minimal influence on visual acuity. The individual might encounter indications like agony, inflammation, and uneasiness in the affected eye, but their visual acuity could continue to be relatively steady or only slightly impacted.
Reduced Visual Acuity: TASS frequently manifests with a reduction in visual acuity. The inflammation and swelling in the front section can lead to hazy vision, reduced sharpness, and impaired visual performance.
DIFFERENTIAL DIAGNOSIS
Endophthalmitis: It is a serious infection within the eye that can happen after eye surgery. It shows similar symptoms to TASS, such as pain, redness, reduced visual acuity, and inflammation of the front chamber.
Sterile Inflammation: Some patients may experience an aseptic inflammatory reaction after eye surgery, which can imitate the signs and symptoms of TASS.
Anterior Uveitis: Non-infectious anterior uveitis or iritis can present with anterior chamber inflammation, pain, redness, and decreased visual acuity.
Corneal Decompensation: Patients with pre-existing corneal endothelial dysfunction or corneal diseases may experience corneal decompensation after eye surgery. Corneal decompensation can show up with corneal swelling, hazy vision, and decreased visual acuity.
TREATMENT PARADIGM
Modification of Environment:
These can be an important aspect of managing Toxic Anterior Segment Syndrome (TASS) to minimize further exposure to potential contaminants and support the healing process.
Surgical Environment: Enforcing sterile measures in the operating room is vital in avoiding the development of TASS.
Surgical Apparatus and Materials: Conducting periodic assessments and upkeep of surgical apparatus and materials are imperative in averting pollution and the influx of harmful elements.
Irrigation Fluids: Exercising caution and diligence in scrutinizing the composition and standard of irrigation fluids utilized during surgery is indispensable.
Administration of Pharmaceutical Agents with Drugs:
The administration of pharmaceutical agents in the management of Toxic Anterior Segment Syndrome (TASS) aims to control inflammation, alleviate symptoms, and promote healing.
Nonsteroidal Anti-Inflammatory drugs (NSAIDs): Topical NSAIDs can be suggested as a complement to steroids or as a substitute in specific situations. They help in reducing pain, inflammation, and related symptoms. Ketorolac tromethamine, nepafenac, or bromfenac are some of the frequently used NSAIDs.
Artificial Lubricants: Eye drops that lubricate or artificial tears might be advised to alleviate dryness and enhance comfort in TASS. They assist in preserving the hydration of the ocular surface and mitigating symptoms of dryness and irritation.
Intervention with a Procedure:
Capsular Bag rinse or Replacement: If there are indications of any remaining pollutants or harmful substances inside the lens capsule post cataract surgery, a capsular bag irrigation or replacement could be contemplated.
Laser Capsulotomy: In some cases, posterior capsule opacification (PCO) may arise simultaneously with TASS or because of the inflammatory reaction. PCO can lead to visual disruptions and may necessitate treatment.
Phase of Management:
Initial Diagnosis: The initial step comprises of timely identification and diagnosis of TASS. This necessitates a heightened level of suspicion grounded on the patient’s indications, clinical examination outcomes, and familiarity with the surgical procedure conducted.
Immediate treatment: Upon confirmation of TASS, prompt management is commenced to manage inflamed areas, alleviate indications, and prevent additional harm. This encompasses the dispensation of topical drugs like corticosteroids and NSAIDs to decrease inflammation and alleviate discomfort.
Supportive Care: Supportive care is an essential aspect of TASS management. It includes measures to maintain ocular hygiene, promote comfort, and prevent complications.
Rehabilitation and Visual Recovery: Once the acute phase of TASS is resolved, rehabilitation and visual recovery become the focus. This may involve addressing any residual visual impairment and managing posterior capsule opacification.
Toxic anterior segment syndrome-an updated review | BMC Ophthalmology | Full Text (biomedcentral.com)
medtigo
Toxic Anterior Segment Syndrome
Updated :
August 30, 2023
Toxic anterior segment syndrome (TASS) is identified by aseptic postoperative inflammation of the front part of the eye after intraocular surgery. While TASS usually appears after cataract surgery, it has also been observed after keratoplasty and surgeries involving the back part of the eye.
The inflammation can range from mild with a low cellular response to severe enough to cause significant cornea swelling and hypopyon. It can occur rapidly (within days) or later (after several months). A broad case series found the overall occurrence of TASS to be 0.22%.
Incidence: The reported incidence of TASS varies across studies. The incidence rates range from 0.03% to 3% of cases following cataract surgery.
Visual outcome: The visual result after TASS treatment varies based on the seriousness of the ailment and the promptness of intervention. With proper care, most patients observe considerable enhancement in their visual sharpness.
Outbreaks: it can sometimes occur in multiple cases, impacting numerous patients in a particular period and area. Outbreaks are usually linked to a shared origin of pollution or incorrect medical procedures.
Precautionary measures: The occurrence of TASS has reduced with time owing to better comprehension and compliance with aseptic protocols. Medical facilities have emphasized improving sterilization methods for instruments, appropriate storage, and preparation of irrigation solutions.
Toxic anterior segment syndrome is a consequence of the accidental introduction of noxious agents into the front part of the eye. This triggers a significant inflammatory response that can differ in severity depending on the nature and duration of the harmful substance.
The acute and severe inflammatory reaction is due to cellular necrosis or apoptosis as well as damage to the surrounding tissue. The corneal endothelium is frequently the most affected structure, as it is not able to regenerate or replace deceased cells.
Toxic agents specifically trigger the sudden disintegration of endothelial connections, resulting in the loss of the barrier’s functionality. Therefore, the surviving endothelial cells attempt to uphold the endothelial pumping mechanism by migrating and extending over the affected regions.
Residual sterilization agents: Improper rinsing or inadequate removal of sterilizing agents used for surgical instruments can lead to their introduction into the eye during surgery.
Ophthalmic visco-surgical devices (OVDs): OVDs are commonly used during cataract surgery to maintain the stability of the anterior chamber and protect delicate tissues.
Improperly prepared irrigating solutions: The irrigating solutions used during surgery, such as balanced salt solutions, can be a potential source of contaminants.
These factors can help clinicians assess the prognosis and guide treatment decisions.
Severity of Inflammation: The scope and seriousness of inflammation in the front part of the eye have an impact on the prediction of TASS.
Fundamental Eye Health: Individuals with weakened eye structures, such as pre-existing corneal illness or glaucoma, may face more difficulties in controlling the inflammation and obtaining the best visual results.
Response to Treatment: Patients who exhibit a timely and favorable response to anti-inflammatory treatments, such as topical or systemic corticosteroids, generally have a better prediction than those with a poor response or stubborn inflammation.
CLINICAL HISTORY
Age Group: Toxic Anterior Segment Syndrome (TASS) can affect individuals across various age groups, including both younger and older individuals.
PHYSICAL EXAMINATION
Slit Lamp Examination: A slit lamp biomicroscope is used to examine the anterior segment of the eye in detail. It includes mainly,
Swelling of the Cornea: The cornea might display indications of puffiness or swelling, causing a cloudy or indistinct appearance. The amount of corneal swelling can differ based on the harshness of TASS.
Fibrin or hypopyon: In serious circumstances, fibrin could be detected in the front chamber, showing up as slimy or lumpy substance.
Redness of the Conjunctiva: The conjunctiva may seem crimson or irritated due to the existence of inflammation in the front part.
Visual Acuity: Visual acuity is measured using a Snellen chart or an appropriate visual acuity test.
Associated Comorbidity or Activity:
Systemic Health Conditions: Some general health conditions can impact the overall health and ability to heal of the eye, which could potentially impact the development and outcome of TASS.
Hypersensitivities and Allergies: People with known sensitivities or a past of allergic reactions may have a higher chance of developing TASS.
Previous Eye Operations: Individuals who have had previous intraocular surgeries or experienced complications from ocular procedures may be more prone to TASS.
Acuity of Presentation:
The visual acuity at presentation of Toxic Anterior Segment Syndrome (TASS) may differ based on the gravity of the ailment and the patient. Generally, TASS presents within the initial 12 to 48 hours after intraocular surgery, predominantly cataract surgery.
Unaffected Visual Acuity: TASS may present with minimal influence on visual acuity. The individual might encounter indications like agony, inflammation, and uneasiness in the affected eye, but their visual acuity could continue to be relatively steady or only slightly impacted.
Reduced Visual Acuity: TASS frequently manifests with a reduction in visual acuity. The inflammation and swelling in the front section can lead to hazy vision, reduced sharpness, and impaired visual performance.
DIFFERENTIAL DIAGNOSIS
Endophthalmitis: It is a serious infection within the eye that can happen after eye surgery. It shows similar symptoms to TASS, such as pain, redness, reduced visual acuity, and inflammation of the front chamber.
Sterile Inflammation: Some patients may experience an aseptic inflammatory reaction after eye surgery, which can imitate the signs and symptoms of TASS.
Anterior Uveitis: Non-infectious anterior uveitis or iritis can present with anterior chamber inflammation, pain, redness, and decreased visual acuity.
Corneal Decompensation: Patients with pre-existing corneal endothelial dysfunction or corneal diseases may experience corneal decompensation after eye surgery. Corneal decompensation can show up with corneal swelling, hazy vision, and decreased visual acuity.
TREATMENT PARADIGM
Modification of Environment:
These can be an important aspect of managing Toxic Anterior Segment Syndrome (TASS) to minimize further exposure to potential contaminants and support the healing process.
Surgical Environment: Enforcing sterile measures in the operating room is vital in avoiding the development of TASS.
Surgical Apparatus and Materials: Conducting periodic assessments and upkeep of surgical apparatus and materials are imperative in averting pollution and the influx of harmful elements.
Irrigation Fluids: Exercising caution and diligence in scrutinizing the composition and standard of irrigation fluids utilized during surgery is indispensable.
Administration of Pharmaceutical Agents with Drugs:
The administration of pharmaceutical agents in the management of Toxic Anterior Segment Syndrome (TASS) aims to control inflammation, alleviate symptoms, and promote healing.
Nonsteroidal Anti-Inflammatory drugs (NSAIDs): Topical NSAIDs can be suggested as a complement to steroids or as a substitute in specific situations. They help in reducing pain, inflammation, and related symptoms. Ketorolac tromethamine, nepafenac, or bromfenac are some of the frequently used NSAIDs.
Artificial Lubricants: Eye drops that lubricate or artificial tears might be advised to alleviate dryness and enhance comfort in TASS. They assist in preserving the hydration of the ocular surface and mitigating symptoms of dryness and irritation.
Intervention with a Procedure:
Capsular Bag rinse or Replacement: If there are indications of any remaining pollutants or harmful substances inside the lens capsule post cataract surgery, a capsular bag irrigation or replacement could be contemplated.
Laser Capsulotomy: In some cases, posterior capsule opacification (PCO) may arise simultaneously with TASS or because of the inflammatory reaction. PCO can lead to visual disruptions and may necessitate treatment.
Phase of Management:
Initial Diagnosis: The initial step comprises of timely identification and diagnosis of TASS. This necessitates a heightened level of suspicion grounded on the patient’s indications, clinical examination outcomes, and familiarity with the surgical procedure conducted.
Immediate treatment: Upon confirmation of TASS, prompt management is commenced to manage inflamed areas, alleviate indications, and prevent additional harm. This encompasses the dispensation of topical drugs like corticosteroids and NSAIDs to decrease inflammation and alleviate discomfort.
Supportive Care: Supportive care is an essential aspect of TASS management. It includes measures to maintain ocular hygiene, promote comfort, and prevent complications.
Rehabilitation and Visual Recovery: Once the acute phase of TASS is resolved, rehabilitation and visual recovery become the focus. This may involve addressing any residual visual impairment and managing posterior capsule opacification.
Toxic anterior segment syndrome-an updated review | BMC Ophthalmology | Full Text (biomedcentral.com)
Loading...
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
